Indian Immunologicals Limited

18/09/2025

Dr. K. Anand Kumar, Managing Director, Indian Immunologicals Limited (IIL) welcomed the Chief Veterinary Officer, Dr Mary Van Andel, from the Ministry for Primary Industries, New Zealand accompanied by two officers, Mr. Eshan Jayawardena, Manager, Trade Plan Implementation and Ms. Kethoseno Peseyia, Policy Advisor, High Commission of New Zealand, New Delhi. The visiting team went around IIL’s state-of-the-art manufacturing facilities and understood the capabilities of IIL in the “One Health” space producing high quality human and veterinary vaccines at an affordable cost catering to both domestic and the export markets. The team from New Zealand appreciated the efforts of IIL in its contribution to various national animal disease control programs in India such as FMD, CSF, PPR, and Rabies apart from its prominent role in serving the Ministry of Health and Family Welfare with vaccines under Universal Immunization Programme. MD, IIL emphasised how IIL effectively addressed all three areas of Availability, Affordability and Accessibility of vaccines. Dr Mary suggested that collaborative work can be undertaken to address transboundary diseases. Heads of Functions from the Technical departments were present and interacted with the visiting team.

National Dairy Development Board

05/09/2025

A moment of pride for Indian Immunologicals Limited (IIL)! We are thrilled to announce that Indian Council of Medical Research and IIL have come together in a landmark partnership. An agreement for the development of vaccine for Malaria, a disease that is affecting millions was signed at the inaugural function of the 11th edition of iPhex and IndiaMedTechExpo2025 .

Sr. VP & Head of Production, Dr Santosh Balasaheb Ghadage and VP R&D Dr. Sridhar Kottakota had the privilege of attending this ceremony with the support of the visionary leadership of our MD, Dr.K.Anand Kumar.

A heartfelt thanks to ICMR, for their unwavering trust and collaboration.

We remain committed to developing and supplying high-quality, affordable vaccines, driven by the vision of our Honourable PM: 'Make in India, For the World'. IIL is also developing vaccines for KFD and Zika in collaboration with ICMR.

National Dairy Development Board

04/09/2025

A moment of immense pride for Indian Immunologicals Limited (IIL)!

​We are thrilled to announce that IIL has been awarded the prestigious Overall Export Award, Silver Category, by Pharmexcil (Pharmaceuticals Export Promotion Council of India) at the inaugural function of the 11th edition of iPhex.

​Our Sr. VP & Head of International Business, Sarthak Vasudeva, had the privilege of accepting this honor. This award is a testament to our consistent export performance over the last three years and is a reflection of:

- ​The visionary leadership of our MD, Dr. K. Anand Kumar.

- ​The hard work and strategic focus of our International Business division.

- ​The world-class capabilities of our manufacturing and technical teams.

​This recognition is particularly special as it comes at a time when we have increased our export revenue 10X in the last decade. A heartfelt thanks to all our global partners for their unwavering trust and collaboration.

​We remain committed to developing and supplying high-quality, affordable vaccines, driven by the vision of our Honourable PM: 'Make in India, For the World'.

National Dairy Development Board

​

22/08/2025

Dr. K.Anand Kumar, Managing Director, Indian Immunologicals Limited (IIL) welcomed Dr.Triveni Dutt (Director) and Senior Scientists from the Indian Veterinary Research Institute (IVRI-ICAR) to IIL’s manufacturing facility in Hyderabad. He said that the collaborative efforts between IVRI and IIL have resulted in many vaccines which are currently being used in the millions and sold at a very affordable price.

Dr.Kumar reiterated the commitment of IIL towards science-based solutions to improve productivity and thereby improving income to our livestock farmers. Both the institutes will work on innovative technologies in the areas of poultry, canine and protozoal vaccines addressing the unmet needs of the country.

The Director ICAR-IVRI lauded IIL’s efforts and its extensive portfolio of biologicals and various other pharmaceutical products not only in the Animal Health space but also in human health. During the visit, the Director-IVRI congratulated IIL for creation of state of the art manufacturing facilities with adequate automation that is of scale to meet the nation’s requirements. The team IVRI comprised of Dr S K Singh, Joint Director (Research), Dr Pallab Chaudhury, Joint Director, Bengaluru, Dr. Madhusudhan Hosamani, Principal Scientist and Dr Suresh Basagoudavar, Principal Scientist.

National Dairy Development Board

21/08/2025

Celebrating the care and guidance of our seniors!!

20/08/2025

Indian Immunologicals pledges 5 lakh doses of veterinary anti-rabies vaccine for free roaming dogs.

Click on the article below to know more:

Indian Immunologicals Limited, largest rabies vaccine manufacturer, pledges 5 lakh doses for free roaming dogs in CSR programme.

18/08/2025

Dr.K. Anand Kumar, Managing Director, Indian Immunologicals Ltd, hosted Ms. Mahima Datla, Managing Director, Biological E. Limited at Indian Immunologicals Limited (IIL)’s Gachibowli vaccine manufacturing facility today. During her interaction with MD, IIL and IIL’s top Management team, she appreciated the dedication of the team and IIL’s relentless efforts to serve the society.

National Dairy Development Board

28/07/2025

Dr. K. Anand Kumar, Managing Director of Indian Immunologicals Limited, hosted Dr. Ashwani Kumar, the Pro Vice-Chancellor & Scientific Advisor at Saveetha University, Chennai—an eminent entomologist of international repute with over 37 years of research in vector-borne diseases.

Dr. Kumar highlighted IIL’s strategic partnerships and R&D collaborations that have kept the company at the forefront of innovation, adding that IIL has already introduced a range of vaccines for vector-borne diseases and is actively involved in research in the One Health space that addresses both animals and humans.

Dr. Ashwani Kumar applauded IIL's efforts in novel vaccines and shared his views on the challenges in addressing vector-borne diseases. climate disruption, technical barriers, regulatory hurdles etc and emphasised that Integrated Vector Management is the way to go.

National Dairy Development Board

28/07/2025

𝗛𝗲𝗽𝗮𝘁𝗶𝘁𝗶𝘀 𝗔: 𝗔 𝗛𝗶𝗱𝗱𝗲𝗻 𝗧𝗵𝗿𝗲𝗮𝘁 𝘁𝗵𝗮𝘁 𝗰𝗮𝗻 𝗯𝗲 𝗣𝗿𝗲𝘃𝗲𝗻𝘁𝗲𝗱!

Did you know? Hepatitis A is a highly contagious liver infection that spreads through contaminated food, water, and surfaces.

•It causes 1.5 million cases of clinical hepatitis globally each year.
•Claims 15,000 to 30,000 lives every year worldwide.

But here's the good news — 𝗶𝘁'𝘀 𝗽𝗿𝗲𝘃𝗲𝗻𝘁𝗮𝗯𝗹𝗲.

𝗚𝗲𝘁 𝗩𝗮𝗰𝗰𝗶𝗻𝗮𝘁𝗲𝗱, 𝗦𝘁𝗮𝘆 𝗣𝗿𝗼𝘁𝗲𝗰𝘁𝗲𝗱.
Talk to your doctor today.
Protect yourself and your loved ones from Hepatitis A.

24/07/2025

Dr.K.Anand Kumar, Managing Director and senior executives of IIL Dr. Santosh Ghadage and Dr.K.Srinivas visited the historic Indian Veterinary Research Institute, IVRI, Bareilly and had a fruitful discussion with the Director, Dr.Triveni Dutt and Senior Joint Directors and Scientists on the future of Animal Health in India. An interactive and insightful visit was organised to the Biological Standardisation Laboratory, Biologics Production facility, Veterinary Clinical complex and Extension divisions. Prior to the visits to various divisions, MD IIL presented the crucial role of IIL since 1982 in the manufacture and supply of various animal vaccines to national disease control programs. He also highlighted IIL's entry into human vaccine space in 1998 and how the company has emerged as the Single largest contributor to India achieving self-sufficiency in the field of vaccines. He appreciated the research work undertaken at IVRI, admired the dedication of scientists and was proud that the IIL-IVRI collaboration has resulted in several affordable vaccines being made available for the country such as PPR vaccine, Goat Pox vaccine, Classical Swine Fever vaccine etc. The Director IVRI expressed that the industry and academia should collectively work towards introduction of economically important livestock vaccines. He also requested IIL to provide Industry experience to the scientists in academia.

National Dairy Development Board

22/07/2025

Dr K Anand Kumar, Managing Director, Indian Immunologicals Ltd, along with Dr NSN Bhargav, Sr. Vice President, met Ms Alka Upadhyaya, Secretary, Dept of Animal Husbandry and Dairying, Min of FAHD (DAHD), Government of India. Discussed various topics related to future of animal health and upcoming vaccines for disease prevention and better productivity in livestock.

National Dairy Development Board

16/07/2025

Indian Immunologicals Limited (IIL) participated in BRIC-THSTI hosted Industry Meet "SYNCHN 2025" at Translational Health Science and Technology Institute, Faridabad on 14th July 2025. The event was focused on fostering and strengthening academia-industry collaborations. We joined the industry-student interaction panel, discussing career path in biotech industry.

IIL also joined the 16th Foundation Day of BRIC-THSTI on 15th July 2025, which was presided by Dr Jitendra Singh ji, Honourable Minister of State (IC) for the Ministry of Science & Technology and Ministry of Earth Sciences, Minister of State for PMO, MoPPP, DAE and DoS, Govt. of India.

On the eve of the event, IIL signed a Letter of Intent (LoI) for the joint development of a multivalent poultry vaccine using the nanocage protein-based vaccine platform developed at THSTI. The commemorative LoI signing was done in the presence of honourable minister Dr. Jitendra Singh, Dr. Rajesh Gokhale, Secretary-DBT & DG-BRIC Govt of India at Department of Biotechnology, Dr. Alka Sharma, Senior Adviser/ Scientist-H, DBT, Dr. Ganesan Karthikeyan, Executive Director, BRIC-THSTI and Dr. Jayanta Bhattacharya, Dean - BRIC-THSTI.

Department of Biotechnology, India